OptiBiotix Health plc “updates investors on the significant progress” says Stephen O’Hara, CEO

OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care gave DirectorsTalk the following product development and commercial update on its SlimBiome(R) product platform.

Stephen O’Hara, CEO of OptiBiotix, commented: “This announcement updates investors on the significant progress we have made with partners developing new application and product opportunities to extend the use of SlimBiome(R) across a wider range of products opportunities and territories. We anticipate SlimBiome(R) being the first in a family of products to include: ImmunBiome, WellBiome, OptiBiome(R) and CardioBiome(R), developed using our advanced microbiome modulating technology platforms, to meet industry and consumer need for scientifically proven products to improve health and wellbeing. As the promise of the microbiome materialises into a wider the range of applications and products and we extend into overseas territories the scale of the opportunity enlarges allowing us to fully exploit the revenue generating potential of our products.”

SlimBiome(R) Product and Application Development

Further to the manufacturing and supply agreement with Knighton Foods announced on 1 November 2017, OptiBiotix is launching a new improved version of its SlimBiome(R) product platform. The product development has been achieved using Knighton’s specialised powder technology which makes SlimBiome(R) easier to dissolve, greatly enhancing ease of use, flavour and mouthfeel. This will provide a range of new product and application opportunities with partners in the bakery (e.g. in store bakeries), snacking, food service (e.g. coffee shops) and beverage categories and meet growing consumer demand for ‘on the go’ products.

SlimBiome(R) Product Range Extension

The new improved SlimBiome(R) will be sold as an ingredient in white label format, and in OptiBiotix’s own brand GoFigure(R) range of shakes and bars. New flavours and additions to the SlimBiome(R) and GoFigure(R) product range will be introduced in early 2018 including morning muesli pots, healthy bites and coffee and tea blends as part of a healthy lifestyle brand. This creates the opportunity for multiple revenue streams from sales of ingredients to food manufacturers, white label products to large retailers, and branded products in multiple presentations to meet the needs of a diverse range of national and international markets. This is all part of a series of ongoing developments with a number of international partners and large retailers to extend SlimBiome’s(R) application into a broader range of ‘Health & Wellbeing’ food and beverage products.

SlimBiome(R) Territory Expansion

Further product development is ongoing with a number of international partners to include SlimBiome(R) in territory specific applications including bakery products (e.g. cookies, tortillas), breakfast cereals (puffs and flakes), food toppings (e.g. salad, breakfast) as well as developing country flavour specific options for healthy snacks, yoghurts and cereal bars. These include Tata with specially formulated and flavoured products ranges for the Asian markets, and a number of US partners looking to improve the health and nutritional status of existing snacking, bakery and cereal products.

 

 

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    Optibiotix Health Plc

    More articles like this

    Optibiotix Health Plc

    NutraIngredients Awards shortlist announced

    NutraIngredients is pleased to announce the shortlisted finalists for the 2018 edition of the NutraIngredients Awards … with the winners announced at our exclusive awards evening in Geneva on 16th May. The shortlisted finalistsfor the 10

    Optibiotix Health Plc

    OptiBiotix Health plc Launch of Slimbiome® in Nutri-bites®

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, and high cholesterol, today announced the launch of its award winning SlimBiome® in Nutri-Bites® with its US partner, Cereal Ingredients (“CII”), at the 2018 Natural

    Optibiotix Health Plc

    OptiBiotix Health PLC OptiBiotix Capital Reorganisation

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes announced on 28 November 2017 that it intended to seek a cancellation of its share premium account (the “Capital Reduction”) in

    Optibiotix Health Plc

    Optibiotix Health PLC In a Strong Position

    Optibiotix Health PLC (LON:OPTI) Chief Executive Officer Stephen O’Hara talks to tells Proactive Investors about focussing on the commercialisation of their technology across the company’s platforms.

    Optibiotix Health Plc

    Functional weight loss ingredient, SlimBiome brought to US

    OptiBiotix Health PLC (LON:OPTI), a specialist in the development of functional ingredients to modulate the human microbiome, has entered into a manufacturing and supply agreement with Cereal Ingredients. The agreement grants Cereal Ingredients a licence to

    Optibiotix Health Plc

    SlimBiome® – Supporting hunger-free weight management

    Slimbiome® is OptiBiotix’s patented combination of natural ingredients, identified and developed by leading experts in nutrition and metabolism, which supports scientifically substantiated weight loss claims. In independent tests the component ingredients have shown reductions in calorie intake

    Optibiotix Health Plc

    OptiBiotix Health PLC Proposed Directorate Changes

    OptiBiotix Health PLC (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, today announced that subject to the completion of normal regulatory due diligence Neil Davidson CBE will be appointed as Non- Executive Chairman on 1 January 2018. Adam Reynolds, the current Non-Executive Chairman will

    Optibiotix Health Plc

    Optibiotix Health PLC on Kelloggs’ Sugar Levels Cut

    Following the announcement today from Kelloggs to cut the amount of sugar in its three top selling children’s cereals, we caught up with Stephen O’Hara, CEO of OptiBiotix Health PLC (LON:OPTI) for his thoughts:   “We are really

    Optibiotix Health Plc

    OptiBiotix Health plc will be presenting research at major USA conference

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announced this morning that it will be presenting research data on its microbiome modulators at MicroBiome R&D and Business Collaboration (USA) in San Diego, on 2-3 November 2017. The conference is unique